Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment
Crossref DOI link: https://doi.org/10.1007/s10585-017-9837-y
Published Online: 2017-01-25
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bazzi, Zainab A.
Balun, Jennifer
Cavallo-Medved, Dora
Porter, Lisa A.
Boffa, Michael B. http://orcid.org/0000-0003-1211-3064
Funding for this research was provided by:
Windsor Essex Cancer Centre Foundation
License valid from 2017-01-25